-

Viz.ai Broadens Healthcare System Integrations to Inform Critical Decisions at the Point of Care

Integration capabilities deliver real-time, disease-specific insights to healthcare providers to improve patient care and outcomes

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced expanded interoperability capabilities of Viz.ai One. Viz.ai One is now live on a broad range of marketplace platforms. Viz.ai algorithms and electronic health record (EHR) data work together on one platform to detect suspected disease and communicate results to care teams immediately. These collaborative integrations streamline clinical workflows and help physicians diagnose and treat patients faster to improve patient outcomes.

"Importing these data directly from the EHR has made the Viz.ai app exponentially more valuable and actionable from a physician's perspective,” said Chris Hayner, MD, FCCP, director of the Medical-Surgical Intensive Care Unit (MSICU) at Good Samaritan Hospital in Cincinnati. “From a patient perspective, it now allows a patient suffering from a life threatening pulmonary embolism to instantly have a team of diverse specialists come together fully armed with the information they need to more quickly and appropriately provide them the care they need.”

Viz.ai’s integration capabilities significantly reduce the time and resources needed by healthcare IT such that Viz.ai can integrate with an EHR system with minimal effort required. With EHR data easily accessible in the Viz.ai platform, care teams can receive relevant contextual data such as patient history or specific clinical data needed for alerted cases, for example pulmonary embolism and hypertrophic cardio. Along with EHR integrations, Viz has expanded to integrate with many picture archiving and communication systems (PACS) and radiology worklist systems allowing specialties across the hospital and outpatient space to improve their workflow while bolstering their clinical practice with the use of AI.

“We are excited to offer an easy way to bring Viz.ai together with multiple EHR, radiology worklist, and PACS partners to deliver a unified experience for healthcare systems and our 45,000-user base,” said Gad Sakin, chief product officer at Viz.ai. “Viz.ai’s direct integrations provide more context and relevant patient information to clinicians wherever they are, helping to save more time at the point-of-care and increase efficiency.”

About Viz.ai

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,500+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai OneTM is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

Contacts

Viz.ai


Release Versions

Contacts

Social Media Profiles
More News From Viz.ai

Viz.ai and NCCN Collaborate to Integrate NCCN Guidelines into Clinical Workflows for Oncologists

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced an agreement with the National Comprehensive Cancer Network® (NCCN®). This collaboration integrates NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast, Prostate, and Bladder Cancer into the Viz Oncology Platform making this important information readily available to clinicians when they’re making critical decisions about patient care. Thr...

Viz.ai Appoints Dr. Timothy N. Showalter as First Chief Medical Officer

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the appointment of Tim Showalter, MD, MPH, MBA, as its first Chief Medical Officer (CMO). Dr. Showalter, an accomplished academic radiation oncologist, will lead Viz.ai’s clinical strategy and advance the company’s mission to use artificial intelligence to improve access to life-saving care. He will report to Chris Mansi, MD, CEO and co-founder of Viz.ai. Dr. Sho...

New Data Show Viz.ai’s AI-Enabled ECG Screening Increases Detection and Accelerates Diagnosis of Hypertrophic Cardiomyopathy

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data demonstrating how Viz HCM enables faster, accurate detection of hypertrophic cardiomyopathy (HCM), to help ensure that more patients are identified. Two studies, which will be presented at the American Heart Association (AHA) Scientific Sessions 2025, show Viz.ai’s real-world ability to identify more patients with HCM years earlier than current...
Back to Newsroom